Reaction
Medical Device Site Pain reporting signals
As of the last recalculation, Medical Device Site Pain appears in 555 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 191.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 44 | 191.7 | 192.6 |
| Etonogestrel And Ethinyl Estradiol | 37 | 67.0 | 67.1 |
| Levodopa | 8 | 25.2 | 25.2 |
| Hydromorphone Hydrochloride | 44 | 19.4 | 19.4 |
| Levonorgestrel | 40 | 7.9 | 8.0 |